Want to see TSE:CL full AI Analyst Report?
CL Stock Chart & Stats
C$1.02
-C$0.03(-3.13%)
At close: 4:00 PM EDT
C$1.02
-C$0.03(-3.13%)
Day’s Range― - ―
52-Week RangeC$0.89 - C$3.12
Previous CloseN/A
Volume26.25K
Average Volume (3M)72.58K
Market Cap
C$493.18M
Enterprise ValueC$1.17K
Total Cash (Recent Filing)C$32.87M
Total Debt (Recent Filing)C$592.02M
Price to Earnings (P/E)―
Beta2.01
Next Earnings
Nov 05, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding355,588,680
10 Day Avg. Volume74,234
30 Day Avg. Volume72,581
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.22
Price to Sales (P/S)0.62
P/FCF Ratio10.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.52Price Target Upside147.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.03
Revenue Forecast (FY)C$668.30M
Bulls Say, Bears Say
Bulls Say
Operating ImprovementPositive EBIT and EBITDA, alongside a gross margin near 48%, show that the operating platform is generating meaningful economic value before below-the-line costs. If maintained, this improvement can support reinvestment, strengthen product economics, and provide a foundation for eventual bottom-line profitability.
Strategic Pennsylvania ExpansionAdding nine Pennsylvania retail locations expands Cresco’s direct customer access in a stated core market. More owned dispensary doors can improve brand distribution, increase retail capture, and create additional outlets for its cultivation and wholesale infrastructure, supporting a more integrated market position.
Vertical IntegrationThe combination of cultivation, manufacturing, wholesale distribution, and owned retail allows Cresco to capture value across multiple stages of the cannabis supply chain. In state-restricted markets, this integrated footprint can improve market access, support brand placement, and reinforce scale advantages.
Bears Say
Persistent Net LossesThe company remains unprofitable at the net-income level even after operating metrics improved. A net margin near negative 16% limits internally generated capital, weakens returns for shareholders, and means the business still must convert operating gains into durable earnings before its financial profile materially improves.
Elevated LeverageDebt is high relative to the equity base, while negative ROE indicates that capital is not yet producing bottom-line returns. This combination reduces financial flexibility, increases the importance of sustained operating improvement, and can constrain investment choices if earnings remain below the burden of the capital structure.
Uneven Growth And Cash ConversionHistorical revenue declines followed by a sharp TTM rebound make the growth trajectory difficult to view as consistently durable. At the same time, free cash flow has been volatile and recently weakened, limiting confidence that reported operating improvement will reliably translate into self-funded expansion.
Cresco Labs News
CL FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was C$0.89 and its highest was C$3.12 in the past 12 months.
What is Cresco Labs’s market cap?
Cresco Labs’s market cap is C$493.18M.
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is Nov 05, 2026 which is in 58 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on Aug 06, 2026. The company reported C$0.055 earnings per share for the quarter, beating the consensus estimate of -C$0.022 by C$0.077.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is -0.02.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 355,588,680 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of C$0.055 in its last earnings report, beating expectations of -C$0.022. Following the earnings report the stock price went up 13.333%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in TSE:CL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cresco Labs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$2.52 (147.29% Upside)
C$2.52 (147.29% Upside)
Blogger Sentiment
Bullish
TSE:CL Sentiment 67%
Sector Average 60%
Sector Average 60%
Insider Transactions
Sold Shares
Worth C$110.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 21.0%
Last 30 Days ▲ 21.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.27%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cresco Labs
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
CL Company Deck
CL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a cautiously optimistic outlook: management delivered solid Q1 margins and EBITDA from a streamlined cost structure, achieved meaningful operational and licensing wins (PA store expansion, Ohio openings, Kentucky harvest, Texas license) and provided constructive Q2 growth guidance (~+10% revenue). Offsets include near-term revenue headwinds from the planned California exit and Michigan excise tax, ongoing pricing compression, seasonal cash flow timing, and unresolved regulatory details around rescheduling (including the scope and timing of 280E relief). On balance, operational momentum, accretive M&A activity, and licensing progress outweigh the short-term market and regulatory challenges.View all TSE:CL earnings summariesCL Stock 12 Month Forecast
Average Price Target
C$2.52
▲(147.29% Upside)